Renal Cell Carcinoma (RCC) Clinical Trials

Find Renal Cell Carcinoma (RCC) Clinical Trials Near You

Evaluation of a Decision Aid in the Treatment Planning of Small Renal Tumors

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The objective of this study is to understand how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team will develop a decision aid (DA) using the decision-analytic model to communicate personalized benefit/harm estimates to patients and promote patient-centered treatment of renal tumors.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Male and female post-op and pre-op patients, ages 18 and older, diagnosed with a localized renal tumor up to 4 cm in diameter.

• Patients scheduled for standard-of-care clinical exams with the NYU Urology Department

Locations
United States
New York
NYU Langone Health
RECRUITING
New York
Contact Information
Primary
Stella Kang, MD
Stella.kang@nyulangone.org
212-263-6246
Backup
Samantha Sanger
Samantha.sanger@nyulangone.org
646-501-0086
Time Frame
Start Date: 2022-09-12
Estimated Completion Date: 2026-09
Participants
Target number of participants: 40
Treatments
Experimental: Decision Aid (DA) Web Tool
Active_comparator: Institutional Pamphlet
Related Therapeutic Areas
Sponsors
Leads: NYU Langone Health

This content was sourced from clinicaltrials.gov